Professor Ernst Hafen is based at the Institute of Molecular Systems Biology at ETH Zurich. He studied the developmental and […]
Differences in genetics, physiology, race, ethnicity, age, and sex, as well as numerous other extrinsic factors, are known to affect […]
Availiable on demand here As we move towards an ever more personalised healthcare system, genomics is at the heart of […]
Introduction: Single-cell sequencing technology has been advanced by the falling sequencing costs, a boom in microfluidics and combinatorial indexing strategies. […]
Mathai Mammen, Global Head of R&D at Janssen Pharmaceuticals, presented at MIT AIDM Conference in February earlier this year, giving […]
D4 Europe is packed with case studies, evidence and intelligence that you can take back to your organisation and impact […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
FLG: Could you give us an introduction of yourself and the work you do? I’m Sandra Smieszek and I’m the […]
Dr Rona Strawbridge has been using genetics to try to understand complex diseases, who’s work has focused much on obesity, type 2 diabetes and cardiovascular disease, and more recently serious mental illness. We managed to have a chat with Rona ahead of her speaking at the Festival of Genomics about her work and why she’s excited to be speaking at the festival this year.
Rory Collins, Principal Investigator and Chief Executive of UK Biobank leads this landmark project. We talk to him about some of the research outcomes from UK Biobank, and why he’s excited to be speaking at the Festival of Genomics this January.
